ArticleCell death & disease2022

The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

Carolien Eggermont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.